Charles Liu, Statistician and Product Manager at Cytel will be part of the expert speaker panel at the 7th Annual SCOPE Summit on 23-26th February. This year’s meeting is taking place in Miami, and offers a packed program with tracks covering such varied topics as risk based monitoring, clinical data technology and integration, and managing outsourced clinical trials. SCOPE has become one of the leading events on the conference calendar for clinical operations executives, with 1100 delegates from over 300 companies expected to attend this February.
Charles’ talk, Advances in Feasibility Study Technology: Accurately Predict Enrollment Rates, Identify Problem Areas Sooner with the EnForeSys® Simulation Software will take place at 9:55 on Thursday 25th February and forms part of the Improving Site-Study Activation and Performance track.
Historically, ‘straight line’ enrollment projections have been limited by the inability to take into account various inputs such as different rates of site initiation, site failure, ‘non-linear’ arrival of patients, and potential pauses in enrollment. In model-based approaches, a model of the trial is set up based on how these inputs relate to each other. Powerful computer simulations calculate how likely it is that a study will meet the overall timeline. Strategically, this helps determine where to focus attention and resources.
During his talk, Charles will tackle how to successfully implement model based forecasting approaches and discuss how to:
- Align study team members on the range of input parameters to yield accurate simulations
- Apply simulation results for improved planning
- Move beyond stakeholder’s individual beliefs and toward truly objective assessments of an enrollment plan’s feasibility.
A number of members of the wider Cytel team will also be attending SCOPE 2016. Stop by our booth 507 or contact us to arrange a meeting time in advance with one of our team. We will be happy to discuss your requirements or provide a demo of the Enforesys software.
Related Items of Interest